Evidence map›Paper›PMID 27924617›Full record

ArticleStem cell reviews and reports2017

CXCL12/SDF-1-Dependent Retinal Migration of Endogenous Bone Marrow-Derived Stem Cells Improves Visual Function after Pharmacologically Induced Retinal Degeneration.

Volker Enzmann, Stéphanie Lecaudé, Anna Kruschinski, Axel Vater

Abstract read
PubMed Publisher
In one paragraph

Article in Stem cell reviews and reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Cell Fusion in Reprogramming and Regeneration.Advances in experimental medicine and biology · 2026
    Review
  2. Review
  3. Review
  4. Stem cell therapy in retinal diseases.Neural regeneration research · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Volker EnzmannDepartment of Ophthalmology, University Hospital, University of Bern, Freiburgstrasse 14, 3010, Bern, Switzerland. volker.enzmann@insel.ch.ORCID 0000-0003-4384-4855
Stéphanie LecaudéDepartment of Clinical Research, University of Bern, Bern, Switzerland.
Anna KruschinskiNOXXON Pharma AG, Berlin, Germany.
Axel VaterNOXXON Pharma AG, Berlin, Germany.
Noxxon Pharma (Germany) · DEUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mobilized bone marrow-derived stem cells (BMSC) have been discussed as an alternative strategy for endogenous repair. Thereby, different approaches for BMSC mobilization have been pursued. Herein, the role of a newly discovered oligonucleotide for retinal homing and regeneration capability of BMSCs was investigated in the sodium iodate (NaIO

Indexed as

AnimalsAptamers, NucleotideBone Marrow CellsCell MovementChemokine CXCL12Glial Fibrillary Acidic ProteinGreen Fluorescent ProteinsImmunohistochemistryInjections, IntraocularIodatesMesenchymal Stem CellsMice, Inbred C57BLMice, TransgenicRetinaRetinal DegenerationTubulinAptamers, Nucleotidebeta3 tubulin, mouseChemokine CXCL12Glial Fibrillary Acidic Proteinglial fibrillary astrocytic protein, mouseGreen Fluorescent ProteinsIodatesNOX-A12sodium iodateTubulinBone marrow-derived stem cells (BMSC)L-aptamerMobilizationNOX-A12Olaptesed pegolRetinal degenerationSodium iodateSpiegelmer

Identifiers

PMID27924617
OpenAlexW2560600720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.